Phase 1b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of SPI-1005 in Meniere's Disease
Phase of Trial: Phase I/II
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Ebselen (Primary)
- Indications Meniere's disease
- Focus Adverse reactions
- Sponsors Sound Pharmaceuticals
- 03 Oct 2017 According to a Sound Pharmaceuticals media release, data were submitted for presentation to the Association for Research in Otolaryngology meeting.
- 03 Oct 2017 Results presented in a Sound Pharmaceuticals Media Release.
- 21 Sep 2017 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History